Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
The Lancet. Oncology
|
August 12, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [<sup>18</sup>F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial
Pierre Vera, Sébastien Thureau, Florence Le Tinier, et al.
The Lancet. Oncology
|
August 14, 2022
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial
Virginie Westeel, Pascal Foucher, Arnaud Scherpereel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2025
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer
Pierre Vera, Philippe Giraud, Sébastien Hapdey, et al.
Environmental Science and Pollution Research International
|
April 26, 2023
Main conclusions and perspectives from the collective scientific assessment of the effects of plant protection products on biodiversity and ecosystem services along the land-sea continuum in France and French overseas territories
Stéphane Pesce, Laure Mamy, Wilfried Sanchez, et al.
Environmental Science and Pollution Research International
|
January 31, 2025
Correction to: Main conclusions and perspectives from the collective scientific assessment of the effects of plant protection products on biodiversity and ecosystem services along the land-sea continuum in France and French overseas territories
Stéphane Pesce, Laure Mamy, Wilfried Sanchez, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
The Lancet. Oncology
|
August 12, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [<sup>18</sup>F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial
Pierre Vera, Sébastien Thureau, Florence Le Tinier, et al.
The Lancet. Oncology
|
August 14, 2022
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial
Virginie Westeel, Pascal Foucher, Arnaud Scherpereel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2025
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer
Pierre Vera, Philippe Giraud, Sébastien Hapdey, et al.
Environmental Science and Pollution Research International
|
April 26, 2023
Main conclusions and perspectives from the collective scientific assessment of the effects of plant protection products on biodiversity and ecosystem services along the land-sea continuum in France and French overseas territories
Stéphane Pesce, Laure Mamy, Wilfried Sanchez, et al.
Environmental Science and Pollution Research International
|
January 31, 2025
Correction to: Main conclusions and perspectives from the collective scientific assessment of the effects of plant protection products on biodiversity and ecosystem services along the land-sea continuum in France and French overseas territories
Stéphane Pesce, Laure Mamy, Wilfried Sanchez, et al.
Page
of 5